Pamela Ann Connealy serves as Executive at Pyxis Oncology, Inc., where they oversee executive responsibilities. Since joining the company, Pamela Ann Connealy has executed 10 insider transactions totaling $55.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 7, 2025 involved receiving (via award) 15,000 shares valued at $0.
Pamela Ann Connealy currently holds 48,711 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pamela Ann Connealy has been a net buyer of PYXS stock. They have purchased $55.6K and sold $0 worth of shares.
Pamela Ann Connealy's most recent insider trade was on Aug 7, 2025, when they sold 15,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 26, 2024 | PYXS | $0 | Award | 328,710 | $N/A | Discretionary |
| Nov 29, 2023 | PYXS | $51.7K | Payment | 36,949 | $1.40 | Discretionary |
| Sep 28, 2023 | PYXS | $15.0K | Purchase | 8,000 | $1.87 | Discretionary |
| Sep 27, 2023 | PYXS | $11.9K | Purchase | 6,426 | $1.85 | Discretionary |
| Sep 25, 2023 | PYXS | $20.0K | Purchase | 12,000 | $1.67 | Discretionary |
| Sep 22, 2023 | PYXS | $8.7K | Purchase | 5,000 | $1.74 | Discretionary |
| Sep 7, 2023 | PYXS | $0 | Award | 187,793 | $N/A | Discretionary |
| Jul 20, 2023 | OBIO | $0 | Award | 11,667 | $N/A | Discretionary |